Keywords
Last Name
Institution

Jeffrey Newcorn

TitleASSOCIATE PROFESSOR
InstitutionMount Sinai
DepartmentPsychiatry
Address1425 Madison Avenue
4th Floor, Room 4-48
New York NY 10029
Phone212-659-8705
Fax212-659-8710
    Other Positions
    TitleASSOCIATE PROFESSOR
    InstitutionMount Sinai
    DepartmentPediatrics


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Newcorn JH. Can children with callous and unemotional traits be treated successfully? J Am Acad Child Adolesc Psychiatry. 2013 Dec; 52(12):1257-9.
      View in: PubMed
    2. Clerkin SM, Schulz KP, Berwid OG, Fan J, Newcorn JH, Tang CY, Halperin JM. Thalamo-cortical activation and connectivity during response preparation in adults with persistent and remitted ADHD. Am J Psychiatry. 2013 Sep 1; 170(9):1011-9.
      View in: PubMed
    3. Newcorn JH, Stein MA, Childress AC, Youcha S, White C, Enright G, Rubin J. Randomized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: morning or evening administration. J Am Acad Child Adolesc Psychiatry. 2013 Sep; 52(9):921-30.
      View in: PubMed
    4. Manor I, Newcorn JH, Faraone SV, Adler LA. Efficacy of metadoxine extended release in patients with predominantly inattentive subtype attention-deficit/hyperactivity disorder. Postgrad Med. 2013 Jul; 125(4):181-90.
      View in: PubMed
    5. Nomura Y, Lambertini L, Rialdi A, Lee M, Mystal EY, Grabie M, Manaster I, Huynh N, Finik J, Davey M, Davey K, Ly J, Stone J, Loudon H, Eglinton G, Hurd Y, Newcorn JH, Chen J. Global methylation in the placenta and umbilical cord blood from pregnancies with maternal gestational diabetes, preeclampsia, and obesity. Reprod Sci. 2014 Jan; 21(1):131-7.
      View in: PubMed
    6. Sallee F, Connor DF, Newcorn JH. A review of the rationale and clinical utilization of a2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders. J Child Adolesc Psychopharmacol. 2013 Jun; 23(5):308-19.
      View in: PubMed
    7. Wang GJ, Volkow ND, Wigal T, Kollins SH, Newcorn JH, Telang F, Logan J, Jayne M, Wong CT, Han H, Fowler JS, Zhu W, Swanson JM. Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder. PLoS One. 2013; 8(5):e63023.
      View in: PubMed
    8. Harty SC, Galanopoulos S, Newcorn JH, Halperin JM. Delinquency, aggression, and attention-related problem behaviors differentially predict adolescent substance use in individuals diagnosed with ADHD. Am J Addict. 2013 Nov-Dec; 22(6):543-50.
      View in: PubMed
    9. Manor I, Ben-Hayun R, Aharon-Peretz J, Salomy D, Weizman A, Daniely Y, Megiddo D, Newcorn JH, Biederman J, Adler LA. A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, and tolerability of extended-release metadoxine in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2012 Dec; 73(12):1517-23.
      View in: PubMed
    10. De Sanctis VA, Nomura Y, Newcorn JH, Halperin JM. Childhood maltreatment and conduct disorder: independent predictors of criminal outcomes in ADHD youth. Child Abuse Negl. 2012 Nov-Dec; 36(11-12):782-9.
      View in: PubMed
    11. Schulz KP, Clerkin SM, Fan J, Halperin JM, Newcorn JH. Guanfacine modulates the influence of emotional cues on prefrontal cortex activation for cognitive control. Psychopharmacology (Berl). 2013 Mar; 226(2):261-71.
      View in: PubMed
    12. Ivanov I, Liu X, Clerkin S, Schulz K, Friston K, Newcorn JH, Fan J. Effects of motivation on reward and attentional networks: an fMRI study. Brain Behav. 2012 Nov; 2(6):741-53.
      View in: PubMed
    13. Schulz KP, Fan J, Bédard AC, Clerkin SM, Ivanov I, Tang CY, Halperin JM, Newcorn JH. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2012 Sep; 69(9):952-61.
      View in: PubMed
    14. Adler LA, Shaw DM, Spencer TJ, Newcorn JH, Hammerness P, Sitt DJ, Minerly C, Davidow JV, Faraone SV. Preliminary examination of the reliability and concurrent validity of the attention-deficit/hyperactivity disorder self-report scale v1.1 symptom checklist to rate symptoms of attention-deficit/hyperactivity disorder in adolescents. J Child Adolesc Psychopharmacol. 2012 Jun; 22(3):238-44.
      View in: PubMed
    15. Ivanov I, Liu X, Shulz K, Fan J, London E, Friston K, Halperin JM, Newcorn JH. Parental substance abuse and function of the motivation and behavioral inhibition systems in drug-naïve youth. Psychiatry Res. 2012 Feb 28; 201(2):128-35.
      View in: PubMed
    16. Appel DI, Brinda B, Markowitz JS, Newcorn JH, Zhu HJ. A liquid chromatography/tandem mass spectrometry assay for the analysis of atomoxetine in human plasma and in vitro cellular samples. Biomed Chromatogr. 2012 Nov; 26(11):1364-70.
      View in: PubMed
    17. Volkow ND, Wang GJ, Tomasi D, Kollins SH, Wigal TL, Newcorn JH, Telang FW, Fowler JS, Logan J, Wong CT, Swanson JM. Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. J Neurosci. 2012 Jan 18; 32(3):841-9.
      View in: PubMed
    18. Stein MA, Waldman ID, Charney E, Aryal S, Sable C, Gruber R, Newcorn JH. Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts. J Child Adolesc Psychopharmacol. 2011 Dec; 21(6):581-8.
      View in: PubMed
    19. Adler LA, Shaw DM, Spencer TJ, Newcorn JH, Sitt DJ, Minerly AE, Davidow JV, Faraone SV. Preliminary reliability and validity of a new time-sensitive ADHD symptom scale in adolescents with ADHD. Postgrad Med. 2011 Sep; 123(5):7-13.
      View in: PubMed
    20. Berger-Jenkins E, McKay M, Newcorn J, Bannon W, Laraque D. Parent medication concerns predict underutilization of mental health services for minority children with ADHD. Clin Pediatr (Phila). 2012 Jan; 51(1):65-76.
      View in: PubMed
    21. Harty SC, Ivanov I, Newcorn JH, Halperin JM. The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood. J Child Adolesc Psychopharmacol. 2011 Aug; 21(4):331-9.
      View in: PubMed
    22. Vaughn AJ, Epstein JN, Rausch J, Altaye M, Langberg J, Newcorn JH, Hinshaw SP, Hechtman L, Arnold LE, Swanson JM, Wigal T. Relation between outcomes on a continuous performance test and ADHD symptoms over time. J Abnorm Child Psychol. 2011 Aug; 39(6):853-64.
      View in: PubMed
    23. Ivanov I, Yehuda R, Greenblatt E, Davidow J, Makotkine I, Alfi L, Newcorn JH. The effect of trauma on stress reactivity in aggressive youth. Psychiatry Res. 2011 Oct 30; 189(3):396-402.
      View in: PubMed
    24. Adler LA, Newcorn JH. Administering and evaluating the results of the adult ADHD Self-Report Scale (ASRS) in adolescents. J Clin Psychiatry. 2011 Jun; 72(6):e20.
      View in: PubMed
    25. Adler LA, Newcorn JH. Assessing adolescents using ADHD rating scales. J Clin Psychiatry. 2011 May; 72(5):e17.
      View in: PubMed
    26. Adler LA, Barkley RA, Newcorn JH. Performance improvement CME: adult ADHD. J Clin Psychiatry. 2011 Apr; 72(4):e15.
      View in: PubMed
    27. Newcorn JH. Risks and benefits of available treatments for adult ADHD. J Clin Psychiatry. 2011 Mar; 72(3):e12.
      View in: PubMed
    28. Adler LA, Shaw DM, Spencer TJ, Newcorn JH, Sitt DJ, Morrill M, Davidow JV, Glatt SJ, Faraone SV. Reliability and validity of the Time-Sensitive ADHD Symptom Scale in adults. Compr Psychiatry. 2011 Nov-Dec; 52(6):769-73.
      View in: PubMed
    29. Kaplan G, Newcorn JH. Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder. Pediatr Clin North Am. 2011 Feb; 58(1):99-120, xi.
      View in: PubMed
    30. Halperin JM, Rucklidge JJ, Powers RL, Miller CJ, Newcorn JH. Childhood CBCL bipolar profile and adolescent/young adult personality disorders: a 9-year follow-up. J Affect Disord. 2011 Apr; 130(1-2):155-61.
      View in: PubMed
    31. Staikova E, Marks DJ, Miller CJ, Newcorn JH, Halperin JM. Childhood stimulant treatment and teen depression: is there a relationship? J Child Adolesc Psychopharmacol. 2010 Oct; 20(5):387-93.
      View in: PubMed
    32. Volkow ND, Wang GJ, Newcorn JH, Kollins SH, Wigal TL, Telang F, Fowler JS, Goldstein RZ, Klein N, Logan J, Wong C, Swanson JM. Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Mol Psychiatry. 2011 Nov; 16(11):1147-54.
      View in: PubMed
    33. Sumner CR, Haynes VS, Teicher MH, Newcorn JH. Does placebo response differ between objective and subjective measures in children with attention-deficit/hyperactivity disorder? Postgrad Med. 2010 Sep; 122(5):52-61.
      View in: PubMed
    34. Bédard AC, Trampush JW, Newcorn JH, Halperin JM. Perceptual and motor inhibition in adolescents/young adults with childhood-diagnosed ADHD. Neuropsychology. 2010 Jul; 24(4):424-34.
      View in: PubMed
    35. Newcorn JH, Stein MA, Cooper KM. Dose-response characteristics in adolescents with attention-deficit/hyperactivity disorder treated with OROS methylphenidate in a 4-week, open-label, dose-titration study. J Child Adolesc Psychopharmacol. 2010 Jun; 20(3):187-96.
      View in: PubMed
    36. Mikami AY, Hinshaw SP, Arnold LE, Hoza B, Hechtman L, Newcorn JH, Abikoff HB. Bulimia nervosa symptoms in the multimodal treatment study of children with ADHD. Int J Eat Disord. 2010 Apr; 43(3):248-59.
      View in: PubMed
    37. Chacko A, Newcorn JH, Feirsen N, Uderman JZ. Improving medication adherence in chronic pediatric health conditions: a focus on ADHD in youth. Curr Pharm Des. 2010; 16(22):2416-23.
      View in: PubMed
    38. Kolevzon A, Newcorn JH, Kryzak L, Chaplin W, Watner D, Hollander E, Smith CJ, Cook EH, Silverman JM. Relationship between whole blood serotonin and repetitive behaviors in autism. Psychiatry Res. 2010 Feb 28; 175(3):274-6.
      View in: PubMed
    39. Bédard AC, Schulz KP, Cook EH, Fan J, Clerkin SM, Ivanov I, Halperin JM, Newcorn JH. Dopamine transporter gene variation modulates activation of striatum in youth with ADHD. Neuroimage. 2010 Nov 15; 53(3):935-42.
      View in: PubMed
    40. Newcorn JH, Sutton VK, Zhang S, Wilens T, Kratochvil C, Emslie GJ, D'souza DN, Schuh LM, Allen AJ. Characteristics of placebo responders in pediatric clinical trials of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2009 Dec; 48(12):1165-72.
      View in: PubMed
    41. Solanto M, Newcorn J, Vail L, Gilbert S, Ivanov I, Lara R. Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009 Dec; 19(6):663-71.
      View in: PubMed
    42. Thanos PK, Ivanov I, Robinson JK, Michaelides M, Wang GJ, Swanson JM, Newcorn JH, Volkow ND. Dissociation between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats in baseline performance and methylphenidate response on measures of attention, impulsivity and hyperactivity in a Visual Stimulus Position Discrimination Task. Pharmacol Biochem Behav. 2010 Jan; 94(3):374-9.
      View in: PubMed
    43. Miller CJ, Newcorn JH, Halperin JM. Fading memories: retrospective recall inaccuracies in ADHD. J Atten Disord. 2010 Jul; 14(1):7-14.
      View in: PubMed
    44. Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, Telang F, Fowler JS, Zhu W, Logan J, Ma Y, Pradhan K, Wong C, Swanson JM. Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA. 2009 Sep 9; 302(10):1084-91.
      View in: PubMed
    45. Schulz KP, Clerkin SM, Halperin JM, Newcorn JH, Tang CY, Fan J. Dissociable neural effects of stimulus valence and preceding context during the inhibition of responses to emotional faces. Hum Brain Mapp. 2009 Sep; 30(9):2821-33.
      View in: PubMed
    46. Solanto MV, Schulz KP, Fan J, Tang CY, Newcorn JH. Event-related FMRI of inhibitory control in the predominantly inattentive and combined subtypes of ADHD. J Neuroimaging. 2009 Jul; 19(3):205-12.
      View in: PubMed
    47. Clerkin SM, Schulz KP, Halperin JM, Newcorn JH, Ivanov I, Tang CY, Fan J. Guanfacine potentiates the activation of prefrontal cortex evoked by warning signals. Biol Psychiatry. 2009 Aug 15; 66(4):307-12.
      View in: PubMed
    48. Newcorn JH, Sutton VK, Weiss MD, Sumner CR. Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study. J Am Acad Child Adolesc Psychiatry. 2009 May; 48(5):511-8.
      View in: PubMed
    49. Pappadopulos E, Jensen PS, Chait AR, Arnold LE, Swanson JM, Greenhill LL, Hechtman L, Chuang S, Wells KC, Pelham W, Cooper T, Elliott G, Newcorn JH. Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry. 2009 May; 48(5):501-10.
      View in: PubMed
    50. Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, Epstein JN, Hoza B, Hechtman L, Abikoff HB, Elliott GR, Greenhill LL, Newcorn JH, Wells KC, Wigal T, Gibbons RD, Hur K, Houck PR. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry. 2009 May; 48(5):484-500.
      View in: PubMed
    51. Newcorn JH, Donnelly C. Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder. Mt Sinai J Med. 2009 Apr; 76(2):198-203.
      View in: PubMed
    52. Newcorn JH. Managing ADHD and comorbidities in adults. J Clin Psychiatry. 2009 Feb; 70(2):e40.
      View in: PubMed
    53. Luthra R, Abramovitz R, Greenberg R, Schoor A, Newcorn J, Schmeidler J, Levine P, Nomura Y, Chemtob CM. Relationship between type of trauma exposure and posttraumatic stress disorder among urban children and adolescents. J Interpers Violence. 2009 Nov; 24(11):1919-27.
      View in: PubMed
    54. De Sanctis VA, Trampush JW, Harty SC, Marks DJ, Newcorn JH, Miller CJ, Halperin JM. Childhood maltreatment and conduct disorder: independent predictors of adolescent substance use disorders in youth with attention deficit/hyperactivity disorder. J Clin Child Adolesc Psychol. 2008 Oct; 37(4):785-93.
      View in: PubMed
    55. Newcorn JH. Cardiovascular safety of ADHD medication treatments. CNS Spectr. 2008 Oct; 13(10 Suppl 15):5-8.
      View in: PubMed
    56. Powers RL, Marks DJ, Miller CJ, Newcorn JH, Halperin JM. Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic outcome. J Child Adolesc Psychopharmacol. 2008 Oct; 18(5):449-59.
      View in: PubMed
    57. Nomura Y, Halperin JM, Newcorn JH, Davey C, Fifer WP, Savitz DA, Brooks-Gunn J. The risk for impaired learning-related abilities in childhood and educational attainment among adults born near-term. J Pediatr Psychol. 2009 May; 34(4):406-18.
      View in: PubMed
    58. Miller CJ, Flory JD, Miller SR, Harty SC, Newcorn JH, Halperin JM. Childhood attention-deficit/hyperactivity disorder and the emergence of personality disorders in adolescence: a prospective follow-up study. J Clin Psychiatry. 2008 Sep; 69(9):1477-84.
      View in: PubMed
    59. Newcorn JH. Nonstimulants and emerging treatments in adults with ADHD. CNS Spectr. 2008 Sep; 13(9 Suppl 13):12-6.
      View in: PubMed
    60. Trampush JW, Miller CJ, Newcorn JH, Halperin JM. The impact of childhood ADHD on dropping out of high school in urban adolescents/ young adults. J Atten Disord. 2009 Sep; 13(2):127-36.
      View in: PubMed
    61. Newcorn JH. Co-morbidity in adults with ADHD. CNS Spectr. 2008 Aug; 13(8 Suppl 12):12-5.
      View in: PubMed
    62. Nomura Y, Rajendran K, Brooks-Gunn J, Newcorn JH. Roles of perinatal problems on adolescent antisocial behaviors among children born after 33 completed weeks: a prospective investigation. J Child Psychol Psychiatry. 2008 Oct; 49(10):1108-17.
      View in: PubMed
    63. Harty SC, Miller CJ, Newcorn JH, Halperin JM. Adolescents with childhood ADHD and comorbid disruptive behavior disorders: aggression, anger, and hostility. Child Psychiatry Hum Dev. 2009 Mar; 40(1):85-97.
      View in: PubMed
    64. Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B, Wigal T. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. J Atten Disord. 2008 Jul; 12(1):4-14.
      View in: PubMed
    65. Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B, Wigal T. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details. J Atten Disord. 2008 Jul; 12(1):15-43.
      View in: PubMed
    66. Halperin JM, Trampush JW, Miller CJ, Marks DJ, Newcorn JH. Neuropsychological outcome in adolescents/young adults with childhood ADHD: profiles of persisters, remitters and controls. J Child Psychol Psychiatry. 2008 Sep; 49(9):958-66.
      View in: PubMed
    67. Newcorn JH, Kratochvil CJ, Allen AJ, Casat CD, Ruff DD, Moore RJ, Michelson D. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. Am J Psychiatry. 2008 Jun; 165(6):721-30.
      View in: PubMed
    68. Ivanov I, Schulz KP, London ED, Newcorn JH. Inhibitory control deficits in childhood and risk for substance use disorders: a review. Am J Drug Alcohol Abuse. 2008; 34(3):239-58.
      View in: PubMed
    69. Adler LA, Newcorn JH. The impact, identification, and management of attention-deficit/hyperactivity disorder in adults. Introduction. CNS Spectr. 2007 Dec; 12(12 Suppl 23):1-2.
      View in: PubMed
    70. Newcorn JH. Age-related considerations in the treatment of ADHD. CNS Spectr. 2007 Dec; 12(12 Suppl 23):10-3.
      View in: PubMed
    71. Shemesh E, Annunziato RA, Yehuda R, Shneider BL, Newcorn JH, Hutson C, Cohen JA, Briere J, Gorman JM, Emre S. Childhood abuse, nonadherence, and medical outcome in pediatric liver transplant recipients. J Am Acad Child Adolesc Psychiatry. 2007 Oct; 46(10):1280-9.
      View in: PubMed
    72. Spencer TJ, Kratochvil CJ, Sangal RB, Saylor KE, Bailey CE, Dunn DW, Geller DA, Casat CD, Lipetz RS, Jain R, Newcorn JH, Ruff DD, Feldman PD, Furr AJ, Allen AJ. Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment. J Child Adolesc Psychopharmacol. 2007 Oct; 17(5):689-700.
      View in: PubMed
    73. Newcorn JH, Ivanov I. Psychopharmacologic treatment of attention-deficit/hyperactivity disorder and disruptive behavior disorders. Pediatr Ann. 2007 Sep; 36(9):564-74.
      View in: PubMed
    74. Geller D, Donnelly C, Lopez F, Rubin R, Newcorn J, Sutton V, Bakken R, Paczkowski M, Kelsey D, Sumner C. Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. J Am Acad Child Adolesc Psychiatry. 2007 Sep; 46(9):1119-27.
      View in: PubMed
    75. Kratochvil CJ, Michelson D, Newcorn JH, Weiss MD, Busner J, Moore RJ, Ruff DD, Ramsey J, Dickson R, Turgay A, Saylor KE, Luber S, Vaughan B, Allen AJ. High-dose atomoxetine treatment of ADHD in youths with limited response to standard doses. J Am Acad Child Adolesc Psychiatry. 2007 Sep; 46(9):1128-37.
      View in: PubMed
    76. Miller CJ, Miller SR, Newcorn JH, Halperin JM. Personality characteristics associated with persistent ADHD in late adolescence. J Abnorm Child Psychol. 2008 Feb; 36(2):165-73.
      View in: PubMed
    77. Molina BS, Flory K, Hinshaw SP, Greiner AR, Arnold LE, Swanson JM, Hechtman L, Jensen PS, Vitiello B, Hoza B, Pelham WE, Elliott GR, Wells KC, Abikoff HB, Gibbons RD, Marcus S, Conners CK, Epstein JN, Greenhill LL, March JS, Newcorn JH, Severe JB, Wigal T. Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry. 2007 Aug; 46(8):1028-40.
      View in: PubMed
    78. Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2007 Aug; 64(8):932-40.
      View in: PubMed
    79. Jensen PS, Arnold LE, Swanson JM, Vitiello B, Abikoff HB, Greenhill LL, Hechtman L, Hinshaw SP, Pelham WE, Wells KC, Conners CK, Elliott GR, Epstein JN, Hoza B, March JS, Molina BS, Newcorn JH, Severe JB, Wigal T, Gibbons RD, Hur K. 3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry. 2007 Aug; 46(8):989-1002.
      View in: PubMed
    80. Newcorn JH, Weiss M, Stein MA. The complexity of ADHD: diagnosis and treatment of the adult patient with comorbidities. CNS Spectr. 2007 Aug; 12(8 Suppl 12):1-14; quiz 15-6.
      View in: PubMed
    81. Swanson JM, Elliott GR, Greenhill LL, Wigal T, Arnold LE, Vitiello B, Hechtman L, Epstein JN, Pelham WE, Abikoff HB, Newcorn JH, Molina BS, Hinshaw SP, Wells KC, Hoza B, Jensen PS, Gibbons RD, Hur K, Stehli A, Davies M, March JS, Conners CK, Caron M, Volkow ND. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry. 2007 Aug; 46(8):1015-27.
      View in: PubMed
    82. Swanson JM, Hinshaw SP, Arnold LE, Gibbons RD, Marcus S, Hur K, Jensen PS, Vitiello B, Abikoff HB, Greenhill LL, Hechtman L, Pelham WE, Wells KC, Conners CK, March JS, Elliott GR, Epstein JN, Hoagwood K, Hoza B, Molina BS, Newcorn JH, Severe JB, Wigal T. Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry. 2007 Aug; 46(8):1003-14.
      View in: PubMed
    83. Solanto MV, Gilbert SN, Raj A, Zhu J, Pope-Boyd S, Pope-Boyd S, Stepak B, Vail L, Newcorn JH. Neurocognitive functioning in AD/HD, predominantly inattentive and combined subtypes. J Abnorm Child Psychol. 2007 Oct; 35(5):729-44.
      View in: PubMed
    84. Nomura Y, Wickramaratne PJ, Pilowsky DJ, Newcorn JH, Bruder-Costello B, Davey C, Fifer WP, Brooks-Gunn J, Weissman MM. Low birth weight and risk of affective disorders and selected medical illness in offspring at high and low risk for depression. Compr Psychiatry. 2007 Sep-Oct; 48(5):470-8.
      View in: PubMed
    85. Greenhill LL, Newcorn JH, Gao H, Feldman PD. Effect of two different methods of initiating atomoxetine on the adverse event profile of atomoxetine. J Am Acad Child Adolesc Psychiatry. 2007 May; 46(5):566-72.
      View in: PubMed
    86. Findling RL, Newcorn JH, Malone RP, Waheed A, Prince JB, Kratochvil CJ. Pharmacotherapy of aggression in a 9-year-old with ADHD. J Am Acad Child Adolesc Psychiatry. 2007 May; 46(5):653-8.
      View in: PubMed
    87. Flory JD, Newcorn JH, Miller C, Harty S, Halperin JM. Serotonergic function in children with attention-deficit hyperactivity disorder: relationship to later antisocial personality disorder. Br J Psychiatry. 2007 May; 190:410-4.
      View in: PubMed
    88. Marks DJ, Miller SR, Schulz KP, Newcorn JH, Halperin JM. The interaction of psychosocial adversity and biological risk in childhood aggression. Psychiatry Res. 2007 Jun 30; 151(3):221-30.
      View in: PubMed
    89. Nomura Y, Chemtob CM, Fifer WP, Newcorn JH, Brooks-Gunn J. Additive interaction of child abuse and perinatal risk as signs of resiliency in adulthood. Ann N Y Acad Sci. 2006 Dec; 1094:330-4.
      View in: PubMed
    90. Volkow ND, Wang GJ, Newcorn J, Fowler JS, Telang F, Solanto MV, Logan J, Wong C, Ma Y, Swanson JM, Schulz K, Pradhan K. Brain dopamine transporter levels in treatment and drug naïve adults with ADHD. Neuroimage. 2007 Feb 1; 34(3):1182-90.
      View in: PubMed
    91. Newcorn JH, Michelson D, Kratochvil CJ, Allen AJ, Ruff DD, Moore RJ. Low-dose atomoxetine for maintenance treatment of attention-deficit/hyperactivity disorder. Pediatrics. 2006 Dec; 118(6):e1701-6.
      View in: PubMed
    92. Biederman J, Spencer TJ, Newcorn JH, Gao H, Milton DR, Feldman PD, Witte MM. Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data. Psychopharmacology (Berl). 2007 Jan; 190(1):31-41.
      View in: PubMed
    93. Ivanov IS, Schulz KP, Palmero RC, Newcorn JH. Neurorobiology and evidence-based biological treatments for substance abuse disorders. CNS Spectr. 2006 Nov; 11(11):864-77.
      View in: PubMed
    94. Wells KC, Chi TC, Hinshaw SP, Epstein JN, Pfiffner L, Nebel-Schwalm M, Owens EB, Arnold LE, Abikoff HB, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March J, Newcorn JH, Pelham WE, Severe JB, Swanson J, Vitiello B, Wigal T. Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol. 2006 Aug; 74(4):649-57.
      View in: PubMed
    95. Halperin JM, Kalmar JH, Schulz KP, Marks DJ, Sharma V, Newcorn JH. Elevated childhood serotonergic function protects against adolescent aggression in disruptive boys. J Am Acad Child Adolesc Psychiatry. 2006 Jul; 45(7):833-40.
      View in: PubMed
    96. Wilens TE, Newcorn JH, Kratochvil CJ, Gao H, Thomason CK, Rogers AK, Feldman PD, Levine LR. Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder. J Pediatr. 2006 Jul; 149(1):112-9.
      View in: PubMed
    97. Shemesh E, Annunziato RA, Newcorn JH, Rockmore L, Bierer LM, Cohen JA, Schmeidler J, Yehuda R. Assessment of posttraumatic stress symptoms in children who are medically ill and children presenting to a child trauma program. Ann N Y Acad Sci. 2006 Jul; 1071:472-7.
      View in: PubMed
    98. Epstein JN, Conners CK, Hervey AS, Tonev ST, Arnold LE, Abikoff HB, Elliott G, Greenhill LL, Hechtman L, Hoagwood K, Hinshaw SP, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Wells K, Vitiello B, Wigal T. Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry. 2006 May; 47(5):446-56.
      View in: PubMed
    99. Miller CJ, Miller SR, Trampush J, McKay KE, Newcorn JH, Halperin JM. Family and cognitive factors: modeling risk for aggression in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2006 Mar; 45(3):355-63.
      View in: PubMed
    100. Wilens TE, Kratochvil C, Newcorn JH, Gao H. Do children and adolescents with ADHD respond differently to atomoxetine? J Am Acad Child Adolesc Psychiatry. 2006 Feb; 45(2):149-57.
      View in: PubMed
    101. Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner M, Stein MA, Conners CK, Duby J, Newcorn J, Bailey CE, Kratochvil CJ, Coury D, Casat C, Denisco MJ, Halstead P, Bloom L, Zimmerman BA, Gu J, Cooper KM, Lynch JM. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2006 Jan; 160(1):82-90.
      View in: PubMed
    102. Shemesh E, Yehuda R, Rockmore L, Shneider BL, Emre S, Bartell AS, Schmeidler J, Annunziato RA, Stuber ML, Newcorn JH. Assessment of depression in medically ill children presenting to pediatric specialty clinics. J Am Acad Child Adolesc Psychiatry. 2005 Dec; 44(12):1249-57.
      View in: PubMed
    103. Shemesh E, Annunziato RA, Shneider BL, Newcorn JH, Warshaw JK, Dugan CA, Gelb BD, Kerkar N, Yehuda R, Emre S. Parents and clinicians underestimate distress and depression in children who had a transplant. Pediatr Transplant. 2005 Oct; 9(5):673-9.
      View in: PubMed
    104. Kratochvil CJ, Newcorn JH, Arnold LE, Duesenberg D, Emslie GJ, Quintana H, Sarkis EH, Wagner KD, Gao H, Michelson D, Biederman J. Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry. 2005 Sep; 44(9):915-24.
      View in: PubMed
    105. Jensen PS, Garcia JA, Glied S, Crowe M, Foster M, Schlander M, Hinshaw S, Vitiello B, Arnold LE, Elliott G, Hechtman L, Newcorn JH, Pelham WE, Swanson J, Wells K. Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. Am J Psychiatry. 2005 Sep; 162(9):1628-36.
      View in: PubMed
    106. Spencer TJ, Newcorn JH, Kratochvil CJ, Ruff D, Michelson D, Biederman J. Effects of atomoxetine on growth after 2-year treatment among pediatric patients with attention-deficit/hyperactivity disorder. Pediatrics. 2005 Jul; 116(1):e74-80.
      View in: PubMed
    107. Schulz KP, Tang CY, Fan J, Marks DJ, Newcorn JH, Cheung AM, Halperin JM. Differential prefrontal cortex activation during inhibitory control in adolescents with and without childhood attention-deficit/hyperactivity disorder. Neuropsychology. 2005 May; 19(3):390-402.
      View in: PubMed
    108. Shemesh E, Newcorn JH, Rockmore L, Shneider BL, Emre S, Gelb BD, Rapaport R, Noone SA, Annunziato R, Schmeidler J, Yehuda R. Comparison of parent and child reports of emotional trauma symptoms in pediatric outpatient settings. Pediatrics. 2005 May; 115(5):e582-9.
      View in: PubMed
    109. Hoza B, Gerdes AC, Mrug S, Hinshaw SP, Bukowski WM, Gold JA, Arnold LE, Abikoff HB, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Jensen PS, Kraemer HC, March JS, Newcorn JH, Severe JB, Swanson JM, Vitiello B, Wells KC, Wigal T. Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder. J Clin Child Adolesc Psychol. 2005 Mar; 34(1):74-86.
      View in: PubMed
    110. Newcorn JH, Spencer TJ, Biederman J, Milton DR, Michelson D. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry. 2005 Mar; 44(3):240-8.
      View in: PubMed
    111. Schulz KP, Newcorn JH, Fan J, Tang CY, Halperin JM. Brain activation gradients in ventrolateral prefrontal cortex related to persistence of ADHD in adolescent boys. J Am Acad Child Adolesc Psychiatry. 2005 Jan; 44(1):47-54.
      View in: PubMed
    112. Jensen PS, Eaton Hoagwood K, Roper M, Arnold LE, Odbert C, Crowe M, Molina BS, Hechtman L, Hinshaw SP, Hoza B, Newcorn J, Swanson J, Wells K. The services for children and adolescents-parent interview: development and performance characteristics. J Am Acad Child Adolesc Psychiatry. 2004 Nov; 43(11):1334-44.
      View in: PubMed
    113. Newcorn JH, Miller SR, Ivanova I, Schulz KP, Kalmar J, Marks DJ, Halperin JM. Adolescent outcome of ADHD: impact of childhood conduct and anxiety disorders. CNS Spectr. 2004 Sep; 9(9):668-78.
      View in: PubMed
    114. Schulz KP, Fan J, Tang CY, Newcorn JH, Buchsbaum MS, Cheung AM, Halperin JM. Response inhibition in adolescents diagnosed with attention deficit hyperactivity disorder during childhood: an event-related FMRI study. Am J Psychiatry. 2004 Sep; 161(9):1650-7.
      View in: PubMed
    115. Harty SC, Thorn NK, Kalmar JH, Newcorn JH, Halperin JM. The effect of childhood conduct disorder and cognitive functioning on adolescent substance use. CNS Spectr. 2004 Sep; 9(9):661-6.
      View in: PubMed
    116. Newcorn J. ADHD: current questions and research. CNS Spectr. 2004 Sep; 9(9):638.
      View in: PubMed
    117. Matza LS, Rentz AM, Secnik K, Swensen AR, Revicki DA, Michelson D, Spencer T, Newcorn JH, Kratochvil CJ. The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2004 Jun; 25(3):166-74.
      View in: PubMed
    118. Newcorn JH. Selective serotonin reuptake inhibitor treatment of major depressive disorder in children and adolescents. Curr Psychiatry Rep. 2004 Apr; 6(2):85-7.
      View in: PubMed
    119. Arnold LE, Chuang S, Davies M, Abikoff HB, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, Langworthy-Lam KS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells KC, Wigal T. Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures. J Abnorm Child Psychol. 2004 Feb; 32(1):39-51.
      View in: PubMed
    120. Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics. 2003 Nov; 112(5):e404.
      View in: PubMed
    121. Shemesh E, Keshavarz R, Leichtling NK, Weinberg E, Mousavi A, Sadow K, Newcorn JH, Schmeidler J, Yehuda R. Pediatric emergency department assessment of psychological trauma and posttraumatic stress. Psychiatr Serv. 2003 Sep; 54(9):1277-81.
      View in: PubMed
    122. Halperin JM, Schulz KP, McKay KE, Sharma V, Newcorn JH. Familial correlates of central serotonin function in children with disruptive behavior disorders. Psychiatry Res. 2003 Aug 1; 119(3):205-16.
      View in: PubMed
    123. Arnold LE, Elliot M, Sachs L, Bird H, Kraemer HC, Wells KC, Abikoff HB, Comarda A, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hindshaw SP, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wigal T. Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. J Consult Clin Psychol. 2003 Aug; 71(4):713-27.
      View in: PubMed
    124. Halperin JM, McKay KE, Grayson RH, Newcorn JH. Reliability, validity, and preliminary normative data for the Children's Aggression Scale-Teacher Version. J Am Acad Child Adolesc Psychiatry. 2003 Aug; 42(8):965-71.
      View in: PubMed
    125. Owens EB, Hinshaw SP, Kraemer HC, Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott G, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells KC, Wigal T. Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol. 2003 Jun; 71(3):540-52.
      View in: PubMed
    126. Halperin JM, Newcorn JH, McKay KE, Siever LJ, Sharma V. Growth hormone response to guanfacine in boys with attention deficit hyperactivity disorder: a preliminary study. J Child Adolesc Psychopharmacol. 2003; 13(3):283-94.
      View in: PubMed
    127. Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, Newcorn J, Sallee FR, Sangal RB, Saylor K, West S, Kelsey D, Wernicke J, Trapp NJ, Harder D. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry. 2002 Nov; 159(11):1896-901.
      View in: PubMed
    128. Swanson JM, Arnold LE, Vitiello B, Abikoff HB, Wells KC, Pelham WE, March JS, Hinshaw SP, Hoza B, Epstein JN, Elliott GR, Greenhill LL, Hechtman L, Jensen PS, Kraemer HC, Kotkin R, Molina B, Newcorn JH, Owens EB, Severe J, Hoagwood K, Simpson S, Wigal T, Hanley T. Response to commentary on the multimodal treatment study of ADHD (MTA): mining the meaning of the MTA. J Abnorm Child Psychol. 2002 Aug; 30(4):327-32.
      View in: PubMed
    129. Abikoff HB, Jensen PS, Arnold LL, Hoza B, Hechtman L, Pollack S, Martin D, Alvir J, March JS, Hinshaw S, Vitiello B, Newcorn J, Greiner A, Cantwell DP, Conners CK, Elliott G, Greenhill LL, Kraemer H, Pelham WE, Severe JB, Swanson JM, Wells K, Wigal T. Observed classroom behavior of children with ADHD: relationship to gender and comorbidity. J Abnorm Child Psychol. 2002 Aug; 30(4):349-59.
      View in: PubMed
    130. Kratochvil CJ, Heiligenstein JH, Dittmann R, Spencer TJ, Biederman J, Wernicke J, Newcorn JH, Casat C, Milton D, Michelson D. Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolesc Psychiatry. 2002 Jul; 41(7):776-84.
      View in: PubMed
    131. Schulz KP, Newcorn JH, Schmeidler J, Halperin JM. Lack of seasonal rhythms in central serotonergic function in boys with ADHD. Psychoneuroendocrinology. 2002 May; 27(4):463-73.
      View in: PubMed
    132. Abikoff H, Arnold LE, Newcorn JH, Elliott GR, Hechtman L, Severe JB, Wigal T, Shapiro C, Cantwell DP, Conners CK, Greenhill LL, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Pelham WE, Swanson JM, Vitiello B, Wells KC. Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution. J Am Acad Child Adolesc Psychiatry. 2002 May; 41(5):498-504.
      View in: PubMed
    133. Shemesh E, Bartell A, Newcorn JH. Assessment and treatment of depression in medically ill children. Curr Psychiatry Rep. 2002 Apr; 4(2):88-92.
      View in: PubMed
    134. Newcorn JH. Amphetamine salt compound treatment for adults with attention deficit hyperactivity disorder. Curr Psychiatry Rep. 2002 Apr; 4(2):85-6.
      View in: PubMed
    135. Rieppi R, Greenhill LL, Ford RE, Chuang S, Wu M, Davies M, Abikoff HB, Arnold LE, Conners CK, Elliott GR, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells KC, Wigal T. Socioeconomic status as a moderator of ADHD treatment outcomes. J Am Acad Child Adolesc Psychiatry. 2002 Mar; 41(3):269-77.
      View in: PubMed
    136. Halperin JM, McKay KE, Newcorn JH. Development, reliability, and validity of the children's aggression scale-parent version. J Am Acad Child Adolesc Psychiatry. 2002 Mar; 41(3):245-52.
      View in: PubMed
    137. Marks DJ, Newcorn JH, Halperin JM. Comorbidity in adults with attention-deficit/hyperactivity disorder. Ann N Y Acad Sci. 2001 Jun; 931:216-38.
      View in: PubMed
    138. Newcorn JH. New treatments and approaches for attention deficit hyperactivity disorder. Curr Psychiatry Rep. 2001 Apr; 3(2):87-91.
      View in: PubMed
    139. Schulz KP, Newcorn JH, McKay KE, Himelstein J, Koda VH, Siever LJ, Sharma V, Halperin JM. Relationship between central serotonergic function and aggression in prepubertal boys: effect of age and attention-deficit/hyperactivity disorder. Psychiatry Res. 2001 Feb 14; 101(1):1-10.
      View in: PubMed
    140. Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB, Clevenger W, Davies M, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Newcorn JH, Owens EB, Pelham WE, Schiller E, Severe JB, Simpson S, Vitiello B, Wells K, Wigal T, Wu M. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001 Feb; 40(2):168-79.
      View in: PubMed
    141. Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CK, Arnold LE, Abikoff HB, Elliott G, Hechtman L, Hoza B, March JS, Newcorn JH, Severe JB, Vitiello B, Wells K, Wigal T. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr. 2001 Feb; 22(1):60-73.
      View in: PubMed
    142. Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, March JS, Arnold LE, Cantwell DP, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Pelham WE, Severe JB, Swanson JM, Wells KC, Wigal T, Vitiello B. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001 Feb; 40(2):147-58.
      View in: PubMed
    143. Vitiello B, Severe JB, Greenhill LL, Arnold LE, Abikoff HB, Bukstein OG, Elliott GR, Hechtman L, Jensen PS, Hinshaw SP, March JS, Newcorn JH, Swanson JM, Cantwell DP. Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. J Am Acad Child Adolesc Psychiatry. 2001 Feb; 40(2):188-96.
      View in: PubMed
    144. Newcorn JH, Halperin JM, Jensen PS, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, Elliott GR, Epstein JN, Greenhill LL, Hechtman L, Hinshaw SP, Hoza B, Kraemer HC, Pelham WE, Severe JB, Swanson JM, Wells KC, Wigal T, Vitiello B. Symptom profiles in children with ADHD: effects of comorbidity and gender. J Am Acad Child Adolesc Psychiatry. 2001 Feb; 40(2):137-46.
      View in: PubMed
    145. Greenhill LL, Swanson JM, Vitiello B, Davies M, Clevenger W, Wu M, Arnold LE, Abikoff HB, Bukstein OG, Conners CK, Elliott GR, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Severe JB, Wells K, Wigal T. Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry. 2001 Feb; 40(2):180-7.
      View in: PubMed
    146. Conners CK, Epstein JN, March JS, Angold A, Wells KC, Klaric J, Swanson JM, Arnold LE, Abikoff HB, Elliott GR, Greenhill LL, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, Newcorn JH, Pelham WE, Severe JB, Vitiello B, Wigal T. Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry. 2001 Feb; 40(2):159-67.
      View in: PubMed
    147. Hinshaw SP, Owens EB, Wells KC, Kraemer HC, Abikoff HB, Arnold LE, Conners CK, Elliott G, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Swanson JM, Vitiello B, Wigal T. Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment. J Abnorm Child Psychol. 2000 Dec; 28(6):555-68.
      View in: PubMed
    148. Epstein JN, Conners CK, Erhardt D, Arnold LE, Hechtman L, Hinshaw SP, Hoza B, Newcorn JH, Swanson JM, Vitiello B. Familial aggregation of ADHD characteristics. J Abnorm Child Psychol. 2000 Dec; 28(6):585-94.
      View in: PubMed
    149. March JS, Swanson JM, Arnold LE, Hoza B, Conners CK, Hinshaw SP, Hechtman L, Kraemer HC, Greenhill LL, Abikoff HB, Elliott LG, Jensen PS, Newcorn JH, Vitiello B, Severe J, Wells KC, Pelham WE. Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). J Abnorm Child Psychol. 2000 Dec; 28(6):527-41.
      View in: PubMed
    150. Schulz KP, Himelstein J, Halperin JM, Newcorn JH. Neurobiological models of attention-deficit/hyperactivity disorder: a brief review of the empirical evidence. CNS Spectr. 2000 Jun; 5(6):34-44.
      View in: PubMed
    151. Newcorn JH. A glimpse into key issues in ADHD. CNS Spectr. 2000 Jun; 5(6):25.
      View in: PubMed
    152. Marks DJ, McKay KE, Himelstein J, Walter KJ, Newcorn JH, Halperin JM. Predictors of physical aggression in children with attention-deficit/hyperactivity disorder. CNS Spectr. 2000 Jun; 5(6):52-7.
      View in: PubMed
    153. Bonafina MA, Newcorn JH, McKay KE, Koda VH, Halperin JM. ADHD and reading disabilities: a cluster analytic approach for distinguishing subgroups. J Learn Disabil. 2000 May-Jun; 33(3):297-307.
      View in: PubMed
    154. Himelstein J, Newcorn JH, Halperin JM. The neurobiology of attention-deficit hyperactivity disorder. Front Biosci. 2000 Apr 1; 5:D461-78.
      View in: PubMed
    155. Mitsis EM, Halperin JM, Newcorn JH. Serotonin and aggression in children. Curr Psychiatry Rep. 2000 Apr; 2(2):95-101.
      View in: PubMed
    156. Newcorn JH. The multimodal treatment study of children with attention deficit hyperactivity disorder. Curr Psychiatry Rep. 2000 Apr; 2(2):85-9.
      View in: PubMed
    157. Mitsis EM, McKay KE, Schulz KP, Newcorn JH, Halperin JM. Parent-teacher concordance for DSM-IV attention-deficit/hyperactivity disorder in a clinic-referred sample. J Am Acad Child Adolesc Psychiatry. 2000 Mar; 39(3):308-13.
      View in: PubMed
    158. Marks DJ, Himelstein J, Newcorn JH, Halperin JM. Identification of AD/HD subtypes using laboratory-based measures: a cluster analysis. J Abnorm Child Psychol. 1999 Apr; 27(2):167-75.
      View in: PubMed
    159. Pick LH, Halperin JM, Schwartz ST, Newcorn JH. A longitudinal study of neurobiological mechanisms in boys with attention-deficit hyperactivity disorder: preliminary findings. Biol Psychiatry. 1999 Feb 1; 45(3):371-3.
      View in: PubMed
    160. Donovan AM, Halperin JM, Newcorn JH, Sharma V. Thermal response to serotonergic challenge and aggression in attention deficit hyperactivity disorder children. J Child Adolesc Psychopharmacol. 1999; 9(2):85-91.
      View in: PubMed
    161. Newcorn JH, Schulz K, Harrison M, DeBellis MD, Udarbe JK, Halperin JM. Alpha 2 adrenergic agonists. Neurochemistry, efficacy, and clinical guidelines for use in children. Pediatr Clin North Am. 1998 Oct; 45(5):1099-22, viii.
      View in: PubMed
    162. Schulz KP, McKay KE, Newcorn JH, Sharma V, Gabriel S, Halperin JM. Serotonin function and risk for alcoholism in boys with attention-deficit hyperactivity disorder. Neuropsychopharmacology. 1998 Jan; 18(1):10-7.
      View in: PubMed
    163. Halperin JM, Newcorn JH, Koda VH, Pick L, McKay KE, Knott P. Noradrenergic mechanisms in ADHD children with and without reading disabilities: a replication and extension. J Am Acad Child Adolesc Psychiatry. 1997 Dec; 36(12):1688-97.
      View in: PubMed
    164. Halperin JM, Newcorn JH, Kopstein I, McKay KE, Schwartz ST, Siever LJ, Sharma V. Serotonin, aggression, and parental psychopathology in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1997 Oct; 36(10):1391-8.
      View in: PubMed
    165. Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott G, Greenhill LL, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Pelham WE, Richters JE, Schiller E, Severe JB, Swanson JM, Vereen D, Wells KC. National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. Arch Gen Psychiatry. 1997 Sep; 54(9):865-70.
      View in: PubMed
    166. Applegate B, Lahey BB, Hart EL, Biederman J, Hynd GW, Barkley RA, Ollendick T, Frick PJ, Greenhill L, McBurnett K, Newcorn JH, Kerdyk L, Garfinkel B, Waldman I, Shaffer D. Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials. J Am Acad Child Adolesc Psychiatry. 1997 Sep; 36(9):1211-21.
      View in: PubMed
    167. Schulz KP, Halperin JM, Newcorn JH, Sharma V, Gabriel S. Plasma cortisol and aggression in boys with ADHD. J Am Acad Child Adolesc Psychiatry. 1997 May; 36(5):605-9.
      View in: PubMed
    168. Halperin JM, Newcorn JH, Schwartz ST, Sharma V, Siever LJ, Koda VH, Gabriel S. Age-related changes in the association between serotonergic function and aggression in boys with ADHD. Biol Psychiatry. 1997 Mar 15; 41(6):682-9.
      View in: PubMed
    169. Grayson RH, Halperin JM, Sharma V, Schwartz ST, Koda VH, Newcorn JH. Changes in plasma prolactin and catecholamine metabolite levels following acute needle stick in children. Psychiatry Res. 1997 Mar 3; 69(1):27-32.
      View in: PubMed
    170. Greenhill LL, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, Elliott G, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, March JS, Newcorn J, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells K. Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry. 1996 Oct; 35(10):1304-13.
      View in: PubMed
    171. Koda VH, Halperin JM, Newcorn JH, Schwartz ST, McKay KE. Gender differences in the prolactin response to fenfluramine challenge in children with disruptive behavior disorders. Ann N Y Acad Sci. 1996 Sep 20; 794:369-71.
      View in: PubMed
    172. Halperin JM, Newcorn JH, Matier K, Bedi G, Hall S, Sharma V. Impulsivity and the initiation of fights in children with disruptive behavior disorders. J Child Psychol Psychiatry. 1995 Oct; 36(7):1199-211.
      View in: PubMed
    173. Lahey BB, Applegate B, McBurnett K, Biederman J, Greenhill L, Hynd GW, Barkley RA, Newcorn J, Jensen P, Richters J, et al. DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry. 1994 Nov; 151(11):1673-85.
      View in: PubMed
    174. Lahey BB, Applegate B, Barkley RA, Garfinkel B, McBurnett K, Kerdyk L, Greenhill L, Hynd GW, Frick PJ, Newcorn J, et al. DSM-IV field trials for oppositional defiant disorder and conduct disorder in children and adolescents. Am J Psychiatry. 1994 Aug; 151(8):1163-71.
      View in: PubMed
    175. Newcorn JH, Halperin JM, Schwartz S, Pascualvaca D, Wolf L, Schmeidler J, Sharma V. Parent and teacher ratings of attention-deficit hyperactivity disorder symptoms: implications for case identification. J Dev Behav Pediatr. 1994 Apr; 15(2):86-91.
      View in: PubMed
    176. Halperin JM, Sharma V, Siever LJ, Schwartz ST, Matier K, Wornell G, Newcorn JH. Serotonergic function in aggressive and nonaggressive boys with attention deficit hyperactivity disorder. Am J Psychiatry. 1994 Feb; 151(2):243-8.
      View in: PubMed
    177. Halperin JM, Newcorn JH, Matier K, Sharma V, McKay KE, Schwartz S. Discriminant validity of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1993 Sep; 32(5):1038-43.
      View in: PubMed
    178. Healey JM, Newcorn JH, Halperin JM, Wolf LE, Pascualvaca DM, Schmeidler J, O'Brien JD. The factor structure of ADHD items in DSM-III-R: internal consistency and external validation. J Abnorm Child Psychol. 1993 Aug; 21(4):441-53.
      View in: PubMed
    179. Strain JJ, Newcorn J, Wolf D, Fulop G, Davis W. Considering changes in adjustment disorder. Hosp Community Psychiatry. 1993 Jan; 44(1):13-5.
      View in: PubMed
    180. O'Brien JD, Halperin JM, Newcorn JH, Sharma V, Wolf L, Morganstein A. Psychometric differentiation of conduct disorder and attention deficit disorder with hyperactivity. J Dev Behav Pediatr. 1992 Aug; 13(4):274-7.
      View in: PubMed
    181. Halperin JM, Matier K, Bedi G, Sharma V, Newcorn JH. Specificity of inattention, impulsivity, and hyperactivity to the diagnosis of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1992 Mar; 31(2):190-6.
      View in: PubMed
    182. Matier K, Halperin JM, Sharma V, Newcorn JH, Sathaye N. Methylphenidate response in aggressive and nonaggressive ADHD children: distinctions on laboratory measures of symptoms. J Am Acad Child Adolesc Psychiatry. 1992 Mar; 31(2):219-25.
      View in: PubMed
    183. Newcorn JH, Strain J. Adjustment disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1992 Mar; 31(2):318-26.
      View in: PubMed
    184. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 1991 May; 148(5):564-77.
      View in: PubMed
    185. Halperin JM, Newcorn JH, Sharma V, Healey JM, Wolf LE, Pascualvaca DM, Schwartz S. Inattentive and noninattentive ADHD children: do they constitute a unitary group? J Abnorm Child Psychol. 1990 Aug; 18(4):437-49.
      View in: PubMed
    186. Halperin JM, O'Brien JD, Newcorn JH, Healey JM, Pascualvaca DM, Wolf LE, Young JG. Validation of hyperactive, aggressive, and mixed hyperactive/aggressive childhood disorders: a research note. J Child Psychol Psychiatry. 1990 Mar; 31(3):455-9.
      View in: PubMed
    187. Newcorn JH, Halperin JM, Healey JM, O'Brien JD, Pascualvaca DM, Wolf LE, Morganstein A, Sharma V, Young JG. Are ADDH and ADHD the same or different? J Am Acad Child Adolesc Psychiatry. 1989 Sep; 28(5):734-8.
      View in: PubMed
    188. Pfeffer CR, Newcorn J, Kaplan G, Mizruchi MS, Plutchik R. Subtypes of suicidal and assaultive behaviors in adolescent psychiatric inpatients: a research note. J Child Psychol Psychiatry. 1989 Jan; 30(1):151-63.
      View in: PubMed
    189. Halperin JM, Wolf LE, Pascualvaca DM, Newcorn JH, Healey JM, O'Brien JD, Morganstein A, Young JG. Differential assessment of attention and impulsivity in children. J Am Acad Child Adolesc Psychiatry. 1988 May; 27(3):326-9.
      View in: PubMed
    190. Pfeffer CR, Newcorn J, Kaplan G, Mizruchi MS, Plutchik R. Suicidal behavior in adolescent psychiatric inpatients. J Am Acad Child Adolesc Psychiatry. 1988 May; 27(3):357-61.
      View in: PubMed
    Newcorn's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067